Investigational drug · Phase 2
Pentavalent Meningococcal ABCYW vaccine
Also called: MenPenta
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Healthy Volunteers, Meningococcal Immunization, Meningococcal Immunisation.
Phase 2Last checked: Nov 20, 2026Latest source record: Jan 20, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
2
1 still active
All registered trials
2
Any phase or sponsor naming "Pentavalent Meningococcal ABCYW vaccine"
First trial start
2023
Oct 31, 2023
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "Pentavalent Meningococcal ABCYW vaccine", any sponsor or status.
Conditions studied
As listed on its trial records.
- Healthy Volunteers
- Meningococcal Immunization
- Meningococcal Immunisation
Largest trials
Live from ClinicalTrials.gov: studies naming "Pentavalent Meningococcal ABCYW vaccine" as an intervention, largest first.
- Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and AdolescentsPivotal-lookingCompleted
Sanofi Pasteur, a Sanofi CompanySanofi (SNY)
NCT06128733 · 1,215 participants · Start Oct 31, 2023 · Primary completion Aug 27, 2025
Drug: Pentavalent Meningococcal ABCYW vaccine; MenACYW conjugate vaccine and 6 more · For: Meningococcal Immunisation; Healthy Volunteers
Sites: Birmingham, Alabama; Guntersville, Alabama; Tempe, Arizona · 47 sites in all
- Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and InfantsPivotal-lookingActive, not recruiting
Sanofi Pasteur, a Sanofi CompanySanofi (SNY)
NCT06647407 · 750 participants (planned) · Start Nov 5, 2024 · Primary completion May 17, 2027
Drug: Pentavalent Meningococcal ABCYW vaccine; MenACYW conjugate vaccine and 8 more · For: Meningococcal Immunization; Healthy Volunteers
Sites: Belo Horizonte, Brazil; Curitiba, Brazil; Jindřichův Hradec, Czechia · 39 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Healthy Volunteers
- PPV2323-valent Pneumococcal Polysaccharide Vaccine, lot 1Phase 36 trials
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · Healthy Volunteers, Streptococcus Pneumoniae Infection, Pneumococcal Disease
- PCV21 vaccinePhase 35 trials
Sanofi · Pneumococcal Immunization, Healthy Volunteers
- TDVTAK-003, Tetravalent Dengue VaccinePhase 35 trials
Takeda · Dengue Fever, Healthy Volunteers
- DTap-HepB-IPV-Hib vaccineHexyon, Infanrix hexaPhase 34 trials
Sanofi · Healthy Volunteers, Meningococcal Immunization, Pneumococcal Immunization
- MenACYW conjugate vaccineNimenrixPhase 34 trials
Sanofi · Healthy Volunteers, Meningococcal Immunisation, Meningococcal Immunization
- poliomyelitis vaccinePhase 33 trials
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · Healthy Volunteers, Whooping Cough, Diphtheria
- HexaximHexaxim Vaccine, DTaP-IPV-Hib-HepB vaccinePhase 32 trials
Sanofi · Pneumococcal Immunization, Meningococcal Immunisation, Healthy Volunteers
- IIV-HDstandalonePhase 32 trials
Sanofi · COVID-19 Immunization, Influenza Immunization, Immunization
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from Sanofi.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.